Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Organon & Co before investing.

In this article, we go over a few key elements for understanding Organon & Co’s stock price such as:

• Organon & Co’s current stock price and volume
• Why Organon & Co’s stock price changed recently
• Upgrades and downgrades for OGN from analysts
• OGN’s stock price momentum as measured by its relative strength

About Organon & Co (OGN)

Before we jump into Organon & Co’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Organon & Co. is a global health care company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and established brands. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. The Company’s Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, respiratory, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. The Company operates six manufacturing facilities, which are located in Belgium, Brazil, Indonesia, Mexico, the Netherlands and the United Kingdom.

Want to learn more about Organon & Co’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Organon & Co.

Organon & Co’s Stock Price as of Market Close

As of August 23, 2024, 4:00 PM, CST, Organon & Co’s stock price was $22.36.

Organon & Co is up 7.04% from its previous closing price of $20.89.

During the last market session, Organon & Co’s stock traded between $20.78 and $21.08. Currently, there are 257.29 million shares of Organon & Co stock available for purchase.

Organon & Co’s price-earnings (P/E) ratio is currently at 5.4, which is low compared to the Pharmaceuticals industry median of 25.8. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Organon & Co Stock Price History

Organon & Co’s (OGN) price is currently up 2.29% so far this month.

During the month of August, Organon & Co’s stock price has reached a high of $22.49 and a low of $17.75.

Over the last year, Organon & Co has hit prices as high as $22.61 and as low as $10.84. Year to date, Organon & Co’s stock is down 19.94%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Organon & Co Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of August 22, 2024, there were 4 analysts who downgraded Organon & Co’s stock and 2 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Organon & Co’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Organon & Co’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Organon & Co’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Organon & Co (OGN) by visiting AAII Stock Evaluator.

Relative Price Strength of Organon & Co

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of August 22, 2024, Organon & Co has a weighted four-quarter relative price strength of -0.95%, which translates to a Momentum Score of 64 and is considered to be Strong.

Want to learn more about how Organon & Co is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Organon & Co Stock Price: Bottom Line

As of August 23, 2024, Organon & Co’s stock price is $22.36, which is up 7.04% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Organon & Co stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.